Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2003
05/15/2003CA2469818A1 Anticancer compositions
05/15/2003CA2469406A1 Anticancer compositions
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464528A1 Pharmaceutical composition
05/15/2003CA2463745A1 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins
05/15/2003CA2463705A1 Method of selecting hla-dp4 ligands and the applications thereof
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1310260A1 Mixed chimerism and tolerance
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309592A2 Substituted pyrazoles
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309587A1 Cinnoline compounds
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309563A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309345A2 Cathelicidins as vaccine adjuvants
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1309339A2 Stimulating neutrophil function to treat inflammatory bowel disease
05/14/2003EP1309321A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
05/14/2003EP1246631B1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1162875B1 Plants transformed with thioredoxin
05/14/2003EP1107787B1 Salmonella typhi vaccine compositions
05/14/2003EP1042317B1 Indole derivatives as PKC-inhiboitors
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0797427B1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
05/14/2003CN1418256A Beta glucans from filamentous fungi
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418254A Method for remodelling cell wall polysaccharide structures in plants
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418222A Novel peptide and screening method by using the same
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418110A Remedies for sjoegrens syndrome
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1416898A Prepn process of specific fusion vaccine
05/14/2003CN1416897A Prepn process of expression library fusion vaccine
05/14/2003CN1108163C Women's tonic wine and its preparation method
05/14/2003CN1108162C Men's tonic wine and its preparation method
05/14/2003CN1108161C Yichun wine and its preparation method
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562849 Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562821 For treating arthritis and related disorders, and for treating diseases associated with altered mitochondrial function
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562801 PpGpp and pppGpp as immunomodulatory agents
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 1172